BTYNB T9033
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
MDK6620�is an inhibitor of the oncofetal mRNA-binding protein IMP1 (IC50 = 5 _M for IMP1 binding to c-Myc mRNA).�MDK6620�downregulates _-TrCP1 mRNA and reduces activation of nuclear transcriptional factors-kappa B (NF-_B).�It disrupts this enhancer functi
CAS nr:
304456-62-0
Purity:
98%
Molecular Weight:
309,18
SMILES:
C1=CC=C(C(=C1)C(=O)N)N=CC2=CC=C(S2)Br
Formula:
C12H9BrN2OS
Pathway:
Cell Cycle/Checkpoint,Others,NF-_b
Target:
c-Myc,Others,NF-_B
